VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
72,296
AK1,638
AL5,339
AR3,412
AS44
AZ13,316
CA58,147
CO11,002
CT7,824
DC1,626
DE1,670
FL36,235
FM3
GA13,429
GU82
HI2,195
IA4,332
ID2,473
IL19,261
IN22,568
KS4,284
KY6,945
LA4,714
MA13,886
MD11,901
ME2,997
MH8
MI17,865
MN11,345
MO8,919
MP30
MS2,676
MT2,147
NC15,401
ND1,273
NE2,732
NH2,859
NJ17,232
NM3,702
NV4,071
NY32,763
OH18,072
OK5,940
OR7,954
PA22,457
PR2,104
QM2
RI1,911
SC6,055
SD1,133
TN8,691
TX34,122
UT4,023
VA13,944
VI49
VT1,661
WA13,811
WI10,395
WV2,220
WY805
XB5
XL1
XV2

ID: 1570472
Sex: M
Age: 69
State: IN

Vax Date: 03/19/2021
Onset Date: 03/19/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Shaking; Could not eat; Dizziness, lightheadedness; Fever of 102F; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (Shaking), DECREASED APPETITE (Could not eat), DIZZINESS (Dizziness, lightheadedness) and PYREXIA (Fever of 102F) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 immunisation. Concomitant products included INSULIN for COVID-19 vaccination, METFORMIN, PIOGLITAZONE and PRAVASTATIN for an unknown indication. On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced TREMOR (Shaking), DECREASED APPETITE (Could not eat), DIZZINESS (Dizziness, lightheadedness) and PYREXIA (Fever of 102F). At the time of the report, TREMOR (Shaking), DECREASED APPETITE (Could not eat), DIZZINESS (Dizziness, lightheadedness) and PYREXIA (Fever of 102F) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Treatment information was not provided Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Consumer declined further follow up.

Other Meds: INSULIN; METFORMIN; PIOGLITAZONE; PRAVASTATIN

Current Illness:

ID: 1570473
Sex: F
Age:
State: KY

Vax Date: 02/04/2021
Onset Date: 03/12/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: joint pain in her left shoulder/sore shoulder; A spontaneous report was received from a consumer concerning an 80 years old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced joint pain in her left shoulder/sore shoulder/arthralgia The patient's medical history was not provided. Concomitant product use was not provided by the reporter. The patient received their first of two planned doses of mRNA-1273 (Batch number: Batch number not provided) on 4 Feb 2021 and the patient received their second of two planned doses of mRNA-1273 (Batch number: Batch number not provided) on 11 Mar 2021, approximately one day prior to the onset of the symptoms, via an unknown route in the left arm for prophylaxis of COVID-19 infection. On 12 Mar 2021, the patient experienced joint pain in her left shoulder/sore shoulder. On an unspecified date patient was treated with prednisone and tramadol. No relevant laboratory details were included. Action taken with mRNA-1273 in response to the events was not applicable. The outcomes of the events joint pain in her left shoulder/sore shoulder was not recovered.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1570474
Sex: M
Age: 61
State: NY

Vax Date: 03/19/2021
Onset Date: 03/19/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Woke up sweating on Sunday morning; Spent most of the day in bed on Saturday; headache; muscle cramps in upper leg; Stomach pain; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (muscle cramps in upper leg), ABDOMINAL PAIN UPPER (Stomach pain), BED REST (Spent most of the day in bed on Saturday), HYPERHIDROSIS (Woke up sweating on Sunday morning) and HEADACHE (headache) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination. No Medical History information was reported. On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced MUSCLE SPASMS (muscle cramps in upper leg), ABDOMINAL PAIN UPPER (Stomach pain) and HEADACHE (headache). On 20-Mar-2021, the patient experienced BED REST (Spent most of the day in bed on Saturday). On 21-Mar-2021, the patient experienced HYPERHIDROSIS (Woke up sweating on Sunday morning). On 21-Mar-2021, MUSCLE SPASMS (muscle cramps in upper leg), ABDOMINAL PAIN UPPER (Stomach pain), BED REST (Spent most of the day in bed on Saturday), HYPERHIDROSIS (Woke up sweating on Sunday morning) and HEADACHE (headache) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were provided. No treatment details pertained to the events were provided.

Other Meds:

Current Illness:

ID: 1570475
Sex: F
Age: 77
State: TX

Vax Date: 03/17/2021
Onset Date: 03/17/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Feeling cold; Shaky; Dull headache; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (Feeling cold), CHILLS (Shaky) and HEADACHE (Dull headache) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included LOSARTAN and ASA for an unknown indication. On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced FEELING COLD (Feeling cold), CHILLS (Shaky) and HEADACHE (Dull headache). At the time of the report, FEELING COLD (Feeling cold), CHILLS (Shaky) and HEADACHE (Dull headache) outcome was unknown. Not Provided Concomitant medication included blood pressure medication. Treatment medication included Tylenol. Action taken with mRNA-1273 in response to the event was not applicable. This case was linked to MOD-2021-116559 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Email address added. Newconcomitant medication (ASA) added. Action taken changed from Unknown to Not applicable.

Other Meds: LOSARTAN; ASA

Current Illness:

ID: 1570476
Sex: M
Age: 70
State: TN

Vax Date: 03/16/2021
Onset Date: 03/22/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Redness; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Redness) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. No Medical History information was reported. On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced ERYTHEMA (Redness). At the time of the report, ERYTHEMA (Redness) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medication was reported. No treatment medication was reported.

Other Meds:

Current Illness:

ID: 1570477
Sex: F
Age: 71
State: PA

Vax Date: 02/02/2021
Onset Date: 02/12/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: missed 2nd dose, and now its more than 42 days; Flu like symptoms; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (missed 2nd dose, and now its more than 42 days) and INFLUENZA LIKE ILLNESS (Flu like symptoms) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included VITAMINS NOS and CALCIUM for an unknown indication. On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms). On 02-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (missed 2nd dose, and now its more than 42 days). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. On 02-Mar-2021, PRODUCT DOSE OMISSION ISSUE (missed 2nd dose, and now its more than 42 days) had resolved. At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Most recent FOLLOW-UP information incorporated above includes: On 05-Apr-2021: Updated information included date of birth of the patient, date of the 1st dose of the drug is given on 12-02-2021, batch number, anatomical location, new event Flu like symptoms,concomitant medications and treatment medication.; Sender's Comments: This report refers to a case of Product dose omission issue for mRNA-1273, lot # unknown, with no associated AEs.

Other Meds: VITAMINS NOS; CALCIUM

Current Illness:

ID: 1570478
Sex: F
Age:
State: IN

Vax Date: 03/12/2021
Onset Date: 03/18/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: injection site redness; injection site swelling; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE ERYTHEMA (injection site redness) and VACCINATION SITE SWELLING (injection site swelling) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. Concurrent medical conditions included Drug allergy, Food allergy, Dust allergy, Pollen allergy, Fruit allergy and Fruit allergy. Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for an unknown indication. On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (injection site redness) and VACCINATION SITE SWELLING (injection site swelling). At the time of the report, VACCINATION SITE ERYTHEMA (injection site redness) and VACCINATION SITE SWELLING (injection site swelling) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Patient is also allergic to hay and pine. Treatment information was not provided. Most recent FOLLOW-UP information incorporated above includes: On 12-Jul-2021: Follow-up Information received contains No New Information. On 15-Jul-2021: follow up received and medical history were added.Event dates and patient initial updated. Treatment details were added.

Other Meds: BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]

Current Illness: Drug allergy; Dust allergy; Food allergy; Fruit allergy; Pollen allergy

ID: 1570479
Sex: F
Age: 68
State: FL

Vax Date: 03/04/2021
Onset Date: 03/04/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: swelling of the left side of her face to the eye; electrical pain on the face that did not allow her to talk or eat; electrical pain on the face that did not allow her to talk or eat; very sick; felt really dizzy; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (swelling of the left side of her face to the eye), FACIAL PAIN (electrical pain on the face that did not allow her to talk or eat), SPEECH DISORDER (electrical pain on the face that did not allow her to talk or eat), ILLNESS (very sick) and DIZZINESS (felt really dizzy) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. Concurrent medical conditions included Allergy (DYE ALLERGY) and Trigeminal neuralgia. On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced DIZZINESS (felt really dizzy). On an unknown date, the patient experienced SWELLING FACE (swelling of the left side of her face to the eye), FACIAL PAIN (electrical pain on the face that did not allow her to talk or eat), SPEECH DISORDER (electrical pain on the face that did not allow her to talk or eat) and ILLNESS (very sick). At the time of the report, SWELLING FACE (swelling of the left side of her face to the eye), FACIAL PAIN (electrical pain on the face that did not allow her to talk or eat), SPEECH DISORDER (electrical pain on the face that did not allow her to talk or eat) and ILLNESS (very sick) had not resolved and DIZZINESS (felt really dizzy) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant product use was not provided by the reporter. Treatment information was not provided.

Other Meds:

Current Illness: Allergy (DYE ALLERGY); Trigeminal neuralgia.

ID: 1570480
Sex: F
Age: 75
State: FL

Vax Date: 03/10/2021
Onset Date: 03/14/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Itching on left arm of vaccine; Swelling on arm of vaccine; Sore arm on left side; Redness on arm on arm of vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching on left arm of vaccine), VACCINATION SITE SWELLING (Swelling on arm of vaccine), VACCINATION SITE PAIN (Sore arm on left side) and VACCINATION SITE ERYTHEMA (Redness on arm on arm of vaccine) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included Itchy skin. On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Itching on left arm of vaccine), VACCINATION SITE SWELLING (Swelling on arm of vaccine), VACCINATION SITE PAIN (Sore arm on left side) and VACCINATION SITE ERYTHEMA (Redness on arm on arm of vaccine). At the time of the report, VACCINATION SITE PRURITUS (Itching on left arm of vaccine) and VACCINATION SITE SWELLING (Swelling on arm of vaccine) had not resolved and VACCINATION SITE PAIN (Sore arm on left side) and VACCINATION SITE ERYTHEMA (Redness on arm on arm of vaccine) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication included cream for itchy skin. No treatment medication was reported.

Other Meds:

Current Illness:

ID: 1570481
Sex: F
Age: 72
State: OK

Vax Date: 03/01/2021
Onset Date: 03/02/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: felt like she had Covid; injection site was hot to touch; she couldn't raise her arm above her head; weakness; loss of appetite; diarrhea; fever; body aches; vomiting; her joints hurt for about a week; injection site was swollen; injection site was red; This spontaneous case was reported by a consumer and describes the occurrence of SUSPECTED COVID-19 (felt like she had Covid), VACCINATION SITE WARMTH (injection site was hot to touch), MOBILITY DECREASED (she couldn't raise her arm above her head), ASTHENIA (weakness) and DECREASED APPETITE (loss of appetite) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Diabetic and Blood pressure high. On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced SUSPECTED COVID-19 (felt like she had Covid), VACCINATION SITE WARMTH (injection site was hot to touch), MOBILITY DECREASED (she couldn't raise her arm above her head), ASTHENIA (weakness), DECREASED APPETITE (loss of appetite), DIARRHOEA (diarrhea), PYREXIA (fever), MYALGIA (body aches), VOMITING (vomiting), ARTHRALGIA (her joints hurt for about a week), VACCINATION SITE SWELLING (injection site was swollen) and VACCINATION SITE ERYTHEMA (injection site was red). At the time of the report, SUSPECTED COVID-19 (felt like she had Covid), VACCINATION SITE WARMTH (injection site was hot to touch), MOBILITY DECREASED (she couldn't raise her arm above her head), ASTHENIA (weakness), DECREASED APPETITE (loss of appetite), DIARRHOEA (diarrhea), PYREXIA (fever), MYALGIA (body aches), VOMITING (vomiting), ARTHRALGIA (her joints hurt for about a week), VACCINATION SITE SWELLING (injection site was swollen) and VACCINATION SITE ERYTHEMA (injection site was red) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Nov-2021, SARS-CoV-2 test: positive (Positive) positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications was reported. No treatment details was provided. Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Follow-up received on 10-MAY-2021 and events outcome was updated to resolved. On 22-Jul-2021: No New Information added.

Other Meds:

Current Illness: Blood pressure high; Diabetic

ID: 1570482
Sex: F
Age: 57
State: MI

Vax Date: 03/13/2021
Onset Date: 03/13/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sore at the injection site; tender at the injection site; red at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (red at the injection site), VACCINATION SITE PAIN (sore at the injection site) and VACCINATION SITE PAIN (tender at the injection site) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. The patient's past medical history included Shingles. Concomitant products included PARACETAMOL (TYLENOL), LEVOTHYROXINE SODIUM (SYNTHROID), OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC) and GUAIFENESIN (MUCINEX) for an unknown indication. On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (red at the injection site). On an unknown date, the patient experienced VACCINATION SITE PAIN (sore at the injection site) and VACCINATION SITE PAIN (tender at the injection site). At the time of the report, VACCINATION SITE ERYTHEMA (red at the injection site), VACCINATION SITE PAIN (sore at the injection site) and VACCINATION SITE PAIN (tender at the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.

Other Meds: TYLENOL; SYNTHROID; CLARITIN ALLERGIC; MUCINEX

Current Illness:

ID: 1570483
Sex: F
Age: 59
State: OH

Vax Date: 03/13/2021
Onset Date: 03/13/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: I'm having really bad confusion. I can't think. I can't remember anything. I can't remember anything anybody is telling me. I can't make decisions. I'm really exhausted. I ran into a door.; Sleeping a lot and taking 2 and 3 hour naps and going to bed at 7 or 8 o'clock; I'm having really bad confusion. I can't think. I can't remember anything. I can't remember anything anybody is telling me. I can't make decisions. I'm really exhausted. I ran into a door.; I'm having really bad confusion. I can't think. I can't remember anything. I can't remember anything anybody is telling me. I can't make decisions. I'm really exhausted. I ran into a door.; Sore arm for a few days after the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore arm for a few days after the vaccine), FATIGUE (I'm having really bad confusion. I can't think. I can't remember anything. I can't remember anything anybody is telling me. I can't make decisions. I'm really exhausted. I ran into a door.), CONFUSIONAL STATE (I'm having really bad confusion. I can't think. I can't remember anything. I can't remember anything anybody is telling me. I can't make decisions. I'm really exhausted. I ran into a door.), MEMORY IMPAIRMENT (I'm having really bad confusion. I can't think. I can't remember anything. I can't remember anything anybody is telling me. I can't make decisions. I'm really exhausted. I ran into a door.) and SOMNOLENCE (Sleeping a lot and taking 2 and 3 hour naps and going to bed at 7 or 8 o'clock) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. No Medical History information was reported. On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, the patient experienced VACCINATION SITE PAIN (Sore arm for a few days after the vaccine). On 19-Mar-2021, the patient experienced FATIGUE (I'm having really bad confusion. I can't think. I can't remember anything. I can't remember anything anybody is telling me. I can't make decisions. I'm really exhausted. I ran into a door.), CONFUSIONAL STATE (I'm having really bad confusion. I can't think. I can't remember anything. I can't remember anything anybody is telling me. I can't make decisions. I'm really exhausted. I ran into a door.) and SOMNOLENCE (Sleeping a lot and taking 2 and 3 hour naps and going to bed at 7 or 8 o'clock). On an unknown date, the patient experienced MEMORY IMPAIRMENT (I'm having really bad confusion. I can't think. I can't remember anything. I can't remember anything anybody is telling me. I can't make decisions. I'm really exhausted. I ran into a door.). On 17-Mar-2021, VACCINATION SITE PAIN (Sore arm for a few days after the vaccine) had resolved. At the time of the report, FATIGUE (I'm having really bad confusion. I can't think. I can't remember anything. I can't remember anything anybody is telling me. I can't make decisions. I'm really exhausted. I ran into a door.), CONFUSIONAL STATE (I'm having really bad confusion. I can't think. I can't remember anything. I can't remember anything anybody is telling me. I can't make decisions. I'm really exhausted. I ran into a door.) and MEMORY IMPAIRMENT (I'm having really bad confusion. I can't think. I can't remember anything. I can't remember anything anybody is telling me. I can't make decisions. I'm really exhausted. I ran into a door.) had not resolved and SOMNOLENCE (Sleeping a lot and taking 2 and 3 hour naps and going to bed at 7 or 8 o'clock) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments. No concomitant medications were reported. N treatment medications were reported.

Other Meds:

Current Illness:

ID: 1570484
Sex: F
Age: 64
State: FL

Vax Date: 03/18/2021
Onset Date: 03/19/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Arm a little bit sore; Red rash; A little bit itchy; Bumpy rash all over the trunk of her body; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm a little bit sore), RASH ERYTHEMATOUS (Red rash), RASH PRURITIC (A little bit itchy) and RASH (Bumpy rash all over the trunk of her body) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. Concurrent medical conditions included Cholesterol, Pain and Shingles (patient thought she had a shingles episode). Concomitant products included SIMVASTATIN for Cholesterol, GABAPENTIN for Pain, VALACYCLOVIR [VALACICLOVIR] for Shingles, LEVOTHYROXINE and TRAMADOL for an unknown indication. On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm a little bit sore), RASH ERYTHEMATOUS (Red rash), RASH PRURITIC (A little bit itchy) and RASH (Bumpy rash all over the trunk of her body). On 19-Mar-2021, PAIN IN EXTREMITY (Arm a little bit sore) had resolved. At the time of the report, RASH ERYTHEMATOUS (Red rash), RASH PRURITIC (A little bit itchy) and RASH (Bumpy rash all over the trunk of her body) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment was provided for events.

Other Meds: VALACYCLOVIR [VALACICLOVIR]; LEVOTHYROXINE; SIMVASTATIN; GABAPENTIN; TRAMADOL

Current Illness: Cholesterol; Pain

ID: 1570485
Sex: F
Age:
State: NJ

Vax Date: 02/24/2021
Onset Date: 03/03/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: COVID-19 infection; This spontaneous case was reported by an other health care professional and describes the occurrence of COVID-19 (COVID-19 infection) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced COVID-19 (COVID-19 infection). At the time of the report, COVID-19 (COVID-19 infection) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medication was not reported. Treatment medication was not reported.

Other Meds:

Current Illness:

ID: 1570486
Sex: F
Age: 72
State: OR

Vax Date: 03/04/2021
Onset Date: 03/11/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Tongue is swollen; tongue very sensitive when eating with blisters around the edges; tongue very sensitive when eating with blisters around the edges; a swollen lower lip; Covid-arm rash at the site of the injection down to her elbow; This spontaneous case was reported by a consumer and describes the occurrence of SWOLLEN TONGUE (Tongue is swollen), GLOSSODYNIA (tongue very sensitive when eating with blisters around the edges), BLISTER (tongue very sensitive when eating with blisters around the edges), LIP SWELLING (a swollen lower lip) and VACCINATION SITE RASH (Covid-arm rash at the site of the injection down to her elbow) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21) for COVID-19 vaccination. No Medical History information was reported. On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced SWOLLEN TONGUE (Tongue is swollen), GLOSSODYNIA (tongue very sensitive when eating with blisters around the edges), BLISTER (tongue very sensitive when eating with blisters around the edges), LIP SWELLING (a swollen lower lip) and VACCINATION SITE RASH (Covid-arm rash at the site of the injection down to her elbow). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) on 04-Mar-2021 for Adverse event, at an unspecified dose and frequency. On 18-Mar-2021, VACCINATION SITE RASH (Covid-arm rash at the site of the injection down to her elbow) had resolved. On 28-Mar-2021, SWOLLEN TONGUE (Tongue is swollen), BLISTER (tongue very sensitive when eating with blisters around the edges) and LIP SWELLING (a swollen lower lip) had resolved. At the time of the report, GLOSSODYNIA (tongue very sensitive when eating with blisters around the edges) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications were not provided. This case was linked to MOD-2021-120025 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 31-Mar-2021: Reporter details, patient demographics and event information updated

Other Meds:

Current Illness:

ID: 1570487
Sex: M
Age: 69
State: CA

Vax Date: 02/02/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: hives; This spontaneous case was reported by a patient and describes the occurrence of URTICARIA (hives) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030l20a and 031m20a) for COVID-19 vaccination. The patient's past medical history included Tumour (painful tumor on face) in December 2020. Concomitant products included METFORMIN, GLICLAZIDE, COLCHICINE and LISINOPRIL for an unknown indication. On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On an unknown date, the patient experienced URTICARIA (hives). At the time of the report, URTICARIA (hives) outcome was unknown. Not Provided For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No treatment medication was reported. This case was linked to MOD-2021-059555 (Patient Link).

Other Meds: METFORMIN; GLICLAZIDE; COLCHICINE; LISINOPRIL

Current Illness:

ID: 1570488
Sex: F
Age: 45
State: NC

Vax Date: 02/26/2021
Onset Date: 02/06/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: shortness of oxygen; headaches; positive Covid test; loss of taste; loss of smell; head congestion; throat hurt; fatigue; This spontaneous case was reported by a patient and describes the occurrence of OROPHARYNGEAL PAIN (throat hurt), HEAD DISCOMFORT (head congestion), AGEUSIA (loss of taste), ANOSMIA (loss of smell) and COVID-19 (positive Covid test) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Fatigue. Concomitant products included LEVOTHYROXINE for an unknown indication. On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, the patient experienced FATIGUE (fatigue). On 26-Feb-2021, the patient experienced OROPHARYNGEAL PAIN (throat hurt). On 27-Feb-2021, the patient experienced HEAD DISCOMFORT (head congestion). On 02-Mar-2021, the patient experienced AGEUSIA (loss of taste) and ANOSMIA (loss of smell). On 03-Mar-2021, the patient experienced COVID-19 (positive Covid test). On 08-Mar-2021, the patient experienced HEADACHE (headaches). On 18-Mar-2021, the patient experienced DYSPNOEA (shortness of oxygen). On 27-Feb-2021, OROPHARYNGEAL PAIN (throat hurt) had resolved. On 13-Mar-2021, HEAD DISCOMFORT (head congestion) had resolved. At the time of the report, AGEUSIA (loss of taste) and COVID-19 (positive Covid test) was resolving, ANOSMIA (loss of smell), DYSPNOEA (shortness of oxygen) and HEADACHE (headaches) had not resolved and FATIGUE (fatigue) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No treatment medication was reported.

Other Meds: LEVOTHYROXINE

Current Illness: Fatigue

ID: 1570489
Sex: F
Age:
State: MI

Vax Date: 03/01/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: redness on my arm; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (redness on my arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (redness on my arm). At the time of the report, ERYTHEMA (redness on my arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications were not provided. Treatment information was not reported.

Other Meds:

Current Illness:

ID: 1570490
Sex: F
Age: 65
State: CO

Vax Date: 03/19/2021
Onset Date: 03/19/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: head to toe rash; a red solid band of 4 inches wide on the injection site and on the back which is also very itchy; a red solid band of 4 inches wide, then it appeared on the injection site and on the back; a red solid band of 4 inches wide,then it appeared on injection site and on the back; felt tired; body aches; fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body aches), VACCINATION SITE REACTION (a red solid band of 4 inches wide, then it appeared on the injection site and on the back), RASH (head to toe rash), VACCINATION SITE PRURITUS (a red solid band of 4 inches wide on the injection site and on the back which is also very itchy) and PYREXIA (fever) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 19-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced PAIN (body aches) and PYREXIA (fever). On 20-Mar-2021, the patient experienced FATIGUE (felt tired). On 21-Mar-2021, the patient experienced VACCINATION SITE REACTION (a red solid band of 4 inches wide, then it appeared on the injection site and on the back). 21-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (a red solid band of 4 inches wide on the injection site and on the back which is also very itchy) and VACCINATION SITE ERYTHEMA (a red solid band of 4 inches wide,then it appeared on injection site and on the back). On 22-Mar-2021, the patient experienced RASH (head to toe rash). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and HYDROCORTISONE at an unspecified dose and frequency. At the time of the report, PAIN (body aches), VACCINATION SITE REACTION (a red solid band of 4 inches wide, then it appeared on the injection site and on the back), RASH (head to toe rash), VACCINATION SITE PRURITUS (a red solid band of 4 inches wide on the injection site and on the back which is also very itchy), PYREXIA (fever), FATIGUE (felt tired) and VACCINATION SITE ERYTHEMA (a red solid band of 4 inches wide,then it appeared on injection site and on the back) outcome was unknown. Action taken with mRNA-1273 in response to the events was not applicable. No concomitant medications information was reported. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. This case was linked to MOD-2021-059084 (Patient Link).

Other Meds:

Current Illness:

ID: 1570491
Sex: F
Age: 72
State: NJ

Vax Date: 03/19/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: barely move her arm; felt sick; extreme chills; low grade fever; fatigue; nausea; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (barely move her arm), ILLNESS (felt sick), CHILLS (extreme chills), PYREXIA (low grade fever) and FATIGUE (fatigue) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19. On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LIMB DISCOMFORT (barely move her arm), ILLNESS (felt sick), CHILLS (extreme chills), PYREXIA (low grade fever), FATIGUE (fatigue) and NAUSEA (nausea). At the time of the report, LIMB DISCOMFORT (barely move her arm), ILLNESS (felt sick), CHILLS (extreme chills), PYREXIA (low grade fever), FATIGUE (fatigue) and NAUSEA (nausea) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Nov-2020, SARS-CoV-2 test positive: positive (Positive) mild symptoms, low fever, dry cough, headache, and loss of smell/taste. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant product were not provided. Treatment medication were not reported.

Other Meds:

Current Illness:

ID: 1570492
Sex: F
Age: 67
State: CA

Vax Date: 02/25/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: turning dark pink color big circle around that area; arm started itching at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (turning dark pink color big circle around that area) and VACCINATION SITE PRURITUS (arm started itching at the injection site) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. Concomitant products included MULTIVITAMIN [VITAMINS NOS], ATORVASTATIN and ATENOLOL for an unknown indication. On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE DISCOLOURATION (turning dark pink color big circle around that area) and VACCINATION SITE PRURITUS (arm started itching at the injection site). At the time of the report, VACCINATION SITE DISCOLOURATION (turning dark pink color big circle around that area) and VACCINATION SITE PRURITUS (arm started itching at the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment medicines were not reported.

Other Meds: MULTIVITAMIN [VITAMINS NOS]; ATORVASTATIN; ATENOLOL

Current Illness:

ID: 1570493
Sex: F
Age: 21
State: NJ

Vax Date: 03/12/2021
Onset Date: 03/12/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Extraordinarily burning pain; Itchiness all over body; Rash; Couple of hives; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (Extraordinarily burning pain), PRURITUS (Itchiness all over body), RASH (Rash) and URTICARIA (Couple of hives) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination. No medical history was reported. Concomitant products included DROSPIRENONE, ETHINYLESTRADIOL (GIANVI) for an unknown indication. On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced BURNING SENSATION (Extraordinarily burning pain), PRURITUS (Itchiness all over body), RASH (Rash) and URTICARIA (Couple of hives). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, BURNING SENSATION (Extraordinarily burning pain), RASH (Rash) and URTICARIA (Couple of hives) had resolved and PRURITUS (Itchiness all over body) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: GIANVI

Current Illness:

ID: 1570494
Sex: F
Age:
State: NY

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: No Antibodies detected (lack of efficacy); This spontaneous case was reported by a pharmacist and describes the occurrence of ANTIBODY TEST NEGATIVE (No Antibodies detected (lack of efficacy)) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ANTIBODY TEST NEGATIVE (No Antibodies detected (lack of efficacy)). At the time of the report, ANTIBODY TEST NEGATIVE (No Antibodies detected (lack of efficacy)) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medications were not provided. Treatment information was not reported.

Other Meds:

Current Illness:

ID: 1570495
Sex: F
Age:
State:

Vax Date: 03/01/2021
Onset Date: 03/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Arm is still very sore; Can barely turn my head; Neck pain; Chills; Low fever; Back muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm is still very sore), HYPOKINESIA (Can barely turn my head), NECK PAIN (Neck pain), CHILLS (Chills) and PYREXIA (Low fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19 (Recovered in two weeks without medical intervention.) on 03-Jan-2021. In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced PAIN IN EXTREMITY (Arm is still very sore), HYPOKINESIA (Can barely turn my head), NECK PAIN (Neck pain), CHILLS (Chills), PYREXIA (Low fever) and MYALGIA (Back muscle pain). In March 2021, CHILLS (Chills) and PYREXIA (Low fever) had resolved. At the time of the report, PAIN IN EXTREMITY (Arm is still very sore), HYPOKINESIA (Can barely turn my head), NECK PAIN (Neck pain) and MYALGIA (Back muscle pain) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No laboratory details were provided. No treatment medications were reported.

Other Meds:

Current Illness:

ID: 1570496
Sex: F
Age:
State:

Vax Date: 03/19/2021
Onset Date: 03/19/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Physician suggested to wait for second dose, she did not receive second dose; chills; fever; muscle pain, aches; Joint pain; fatigue; nausea; headache; This spontaneous case was reported by a consumer and describes the occurrence of OFF LABEL USE (Physician suggested to wait for second dose, she did not receive second dose), CHILLS (chills), PYREXIA (fever), MYALGIA (muscle pain, aches) and ARTHRALGIA (Joint pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced CHILLS (chills), PYREXIA (fever), MYALGIA (muscle pain, aches), ARTHRALGIA (Joint pain), FATIGUE (fatigue), NAUSEA (nausea) and HEADACHE (headache). On an unknown date, the patient experienced OFF LABEL USE (Physician suggested to wait for second dose, she did not receive second dose). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, OFF LABEL USE (Physician suggested to wait for second dose, she did not receive second dose) outcome was unknown, CHILLS (chills), PYREXIA (fever), ARTHRALGIA (Joint pain), FATIGUE (fatigue), NAUSEA (nausea) and HEADACHE (headache) was resolving and MYALGIA (muscle pain, aches) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications were not provided. Treatment medication did not help. The patient felt like she was hit by a truck. As of 21-Mar-2021, the patient woke up in the morning feeling better but she still has aches. Most recent FOLLOW-UP information incorporated above includes: On 19-Apr-2021: Lot number and event information updated

Other Meds:

Current Illness:

ID: 1570497
Sex: F
Age:
State: IN

Vax Date: 03/10/2021
Onset Date: 03/18/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: an itchy, red, raised rash at the injection site; an itchy, red, raised rash at the injection site; an itchy, red, raised rash at the injection site; Headache; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE PRURITUS (an itchy, red, raised rash at the injection site), VACCINATION SITE ERYTHEMA (an itchy, red, raised rash at the injection site), VACCINATION SITE RASH (an itchy, red, raised rash at the injection site) and HEADACHE (Headache) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (an itchy, red, raised rash at the injection site), VACCINATION SITE ERYTHEMA (an itchy, red, raised rash at the injection site), VACCINATION SITE RASH (an itchy, red, raised rash at the injection site) and HEADACHE (Headache). At the time of the report, VACCINATION SITE PRURITUS (an itchy, red, raised rash at the injection site), VACCINATION SITE ERYTHEMA (an itchy, red, raised rash at the injection site), VACCINATION SITE RASH (an itchy, red, raised rash at the injection site) and HEADACHE (Headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.

Other Meds:

Current Illness:

ID: 1570498
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Hives in the face and throat; Swelling in the face; Swelling in the throat; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives in the face and throat), SWELLING FACE (Swelling in the face) and PHARYNGEAL SWELLING (Swelling in the throat) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced URTICARIA (Hives in the face and throat), SWELLING FACE (Swelling in the face) and PHARYNGEAL SWELLING (Swelling in the throat). At the time of the report, URTICARIA (Hives in the face and throat), SWELLING FACE (Swelling in the face) and PHARYNGEAL SWELLING (Swelling in the throat) outcome was unknown. No concomitant medications were provided. Treatment medications were unknown. Action taken with mRNA-1273 in response to the events was not applicable.

Other Meds:

Current Illness:

ID: 1570499
Sex: M
Age: 67
State: VA

Vax Date: 03/13/2021
Onset Date: 03/14/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Itchy skin; Red rash; Painful rash; Rash which migrated to top of his biceps and side of the injection site; very intense at the injection site/near rash; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (very intense at the injection site/near rash), PRURITUS (Itchy skin), RASH ERYTHEMATOUS (Red rash), RASH (Painful rash) and RASH (Rash which migrated to top of his biceps and side of the injection site) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination. No Medical History information was reported. On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, the patient experienced VACCINATION SITE REACTION (very intense at the injection site/near rash). On 17-Mar-2021, the patient experienced RASH ERYTHEMATOUS (Red rash), RASH (Painful rash) and RASH (Rash which migrated to top of his biceps and side of the injection site). On an unknown date, the patient experienced PRURITUS (Itchy skin). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, VACCINATION SITE REACTION (very intense at the injection site/near rash), PRURITUS (Itchy skin), RASH ERYTHEMATOUS (Red rash), RASH (Painful rash) and RASH (Rash which migrated to top of his biceps and side of the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. This case was linked to MOD-2021-163283, MOD-2021-163283 Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Follow up received on 25 May 2021 and updated reporter information and event. On 23-Jul-2021: follow up received , email address was added.

Other Meds:

Current Illness:

ID: 1570500
Sex: F
Age:
State: FL

Vax Date: 03/12/2021
Onset Date: 03/15/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: warm at the injection site; large red spot at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (warm at the injection site) and INJECTION SITE ERYTHEMA (large red spot at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced INJECTION SITE WARMTH (warm at the injection site) and INJECTION SITE ERYTHEMA (large red spot at the injection site). At the time of the report, INJECTION SITE WARMTH (warm at the injection site) and INJECTION SITE ERYTHEMA (large red spot at the injection site) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication was reported. No treatment medication was reported.

Other Meds:

Current Illness:

ID: 1570501
Sex: M
Age: 55
State:

Vax Date: 03/16/2021
Onset Date: 03/16/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Light Headed; Pain; Fatigue; Chills; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Light Headed), PAIN (Pain), FATIGUE (Fatigue) and CHILLS (Chills) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, the patient experienced DIZZINESS (Light Headed), PAIN (Pain), FATIGUE (Fatigue) and CHILLS (Chills). On 16-Mar-2021, DIZZINESS (Light Headed) outcome was unknown. On 21-Mar-2021, PAIN (Pain) and FATIGUE (Fatigue) outcome was unknown and CHILLS (Chills) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medicine was reported. No treatment was reported.

Other Meds:

Current Illness:

ID: 1570502
Sex: F
Age: 73
State: CA

Vax Date: 03/09/2021
Onset Date: 03/18/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Warm to the touch at the site of injection; Itchiness at the site of injection; Redness at the site of injection; Fever; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm to the touch at the site of injection), VACCINATION SITE PRURITUS (Itchiness at the site of injection), VACCINATION SITE ERYTHEMA (Redness at the site of injection) and PYREXIA (Fever) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination. No Medical History information was reported. On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Warm to the touch at the site of injection), VACCINATION SITE PRURITUS (Itchiness at the site of injection), VACCINATION SITE ERYTHEMA (Redness at the site of injection) and PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency and CORTISONE for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (Warm to the touch at the site of injection), VACCINATION SITE PRURITUS (Itchiness at the site of injection), VACCINATION SITE ERYTHEMA (Redness at the site of injection) and PYREXIA (Fever) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant product use was not provided by the reporter. Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: follow up received: contains no new information

Other Meds:

Current Illness:

ID: 1570503
Sex: F
Age: 75
State: CA

Vax Date: 01/21/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Long lasting headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Long lasting headache) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042L20A and 024M20A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR) for an unknown indication. On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEADACHE (Long lasting headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency; IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency and NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency. At the time of the report, HEADACHE (Long lasting headache) had not resolved. Patient experienced event for the first vaccine dose which lasted for one day two weeks after administration. Patient informed she also experienced headaches on a daily basis. Action taken with mRNA-1273 in response to the event was not Applicable This case was linked to MOD-2021-053416 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 14-May-2021: Follow-up information received on 14 MAY 2021 and does not contain any new information.

Other Meds: CRESTOR

Current Illness:

ID: 1570504
Sex: F
Age: 66
State: CT

Vax Date: 03/04/2021
Onset Date: 03/04/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Specialist indicated SIRVA; inflamed (the area); pain went from shoulder to wrist; shoulder pain; shot went straight into my shoulder; stuck needle in twice; This spontaneous case was reported by a consumer and describes the occurrence of SHOULDER INJURY RELATED TO VACCINE ADMINISTRATION (Specialist indicated SIRVA), INCORRECT ROUTE OF PRODUCT ADMINISTRATION (shot went straight into my shoulder), WRONG TECHNIQUE IN DEVICE USAGE PROCESS (stuck needle in twice), VACCINATION SITE INFLAMMATION (inflamed (the area)) and PAIN (pain went from shoulder to wrist) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced INCORRECT ROUTE OF PRODUCT ADMINISTRATION (shot went straight into my shoulder) and WRONG TECHNIQUE IN DEVICE USAGE PROCESS (stuck needle in twice). On an unknown date, the patient experienced SHOULDER INJURY RELATED TO VACCINE ADMINISTRATION (Specialist indicated SIRVA), VACCINATION SITE INFLAMMATION (inflamed (the area)), PAIN (pain went from shoulder to wrist) and ARTHRALGIA (shoulder pain). On 04-Mar-2021, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (shot went straight into my shoulder) and WRONG TECHNIQUE IN DEVICE USAGE PROCESS (stuck needle in twice) had resolved. At the time of the report, SHOULDER INJURY RELATED TO VACCINE ADMINISTRATION (Specialist indicated SIRVA), VACCINATION SITE INFLAMMATION (inflamed (the area)) and PAIN (pain went from shoulder to wrist) outcome was unknown and ARTHRALGIA (shoulder pain) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In March 2021, Blood pressure measurement: 179/101 (High) A VERY SCARY 179 / 101. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter. The vaccination was delivered into the rotator cuff and the patient said that the shot was given in the acromioclavicular area. The treatment information included anti-inflammatories (for pain), and physical therapy. Most recent FOLLOW-UP information incorporated above includes: On 06-Apr-2021: Demographics updated On 08-Apr-2021: Follow up received on 8 April 2021 and updated batch number for the first dose, lab data.; Reporter's Comments: This report refers to a case of Product administration error for mRNA-1273, lot # unknown with associated AEs of Shoulder injury related to vaccine administration, arthralgia, vaccination site inflammation and radiating pain Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1570505
Sex: F
Age: 38
State: PA

Vax Date: 01/15/2021
Onset Date: 03/17/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Patient subsequently had a miscarriage and therefore got the second dose of the vaccine today, 17Mar2021 (61 days after first dose); This spontaneous retrospective pregnancy case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient subsequently had a miscarriage and therefore got the second dose of the vaccine today, 17Mar2021 (61 days after first dose)) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 17-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient subsequently had a miscarriage and therefore got the second dose of the vaccine today, 17Mar2021 (61 days after first dose)). The delivery occurred on an unknown date, which was reported as Spontaneous Abortion. For foetus 1, The outcome was reported as Spontaneous Abortion NOS. On 17-Mar-2021, PRODUCT DOSE OMISSION ISSUE (Patient subsequently had a miscarriage and therefore got the second dose of the vaccine today, 17Mar2021 (61 days after first dose)) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to events was not applicable. This case was linked to MOD-2021-048004 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 05-Aug-2021: Follow up received contains:- No new information received.

Other Meds:

Current Illness:

ID: 1570506
Sex: M
Age: 98
State: ME

Vax Date: 02/10/2021
Onset Date: 02/10/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: redness; swelling; rash; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (redness), SWELLING (swelling) and RASH (rash) in a 98-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016M20A and 044A2.) for COVID-19 vaccination. No Medical History information was reported. On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Feb-2021, the patient experienced ERYTHEMA (redness), SWELLING (swelling) and RASH (rash). At the time of the report, ERYTHEMA (redness), SWELLING (swelling) and RASH (rash) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was reported by the reporter Treatment medication included IV antibiotics Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: TCR was received Contains no new information

Other Meds:

Current Illness:

ID: 1570507
Sex: M
Age: 76
State: OH

Vax Date: 02/23/2021
Onset Date: 02/26/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Join discomfort; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Join discomfort) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. No Medical History information was reported. On 23-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced ARTHRALGIA (Join discomfort). At the time of the report, ARTHRALGIA (Join discomfort) outcome was unknown. Not Provided Action taken with mRNA-1273 in response to the event was not applicable. Treatment information was not provided. This case was linked to MOD-2021-059443 (Patient Link).

Other Meds:

Current Illness:

ID: 1570508
Sex: F
Age:
State: TX

Vax Date: 03/19/2021
Onset Date: 03/20/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: a little pain in the arm; trembling; chills; had fever (that was never more than 101.5); malaise in the body; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (malaise in the body), PAIN IN EXTREMITY (a little pain in the arm), TREMOR (trembling), CHILLS (chills) and PYREXIA (had fever (that was never more than 101.5)) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination. The patient's past medical history included COVID-19. On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced MALAISE (malaise in the body), TREMOR (trembling), CHILLS (chills) and PYREXIA (had fever (that was never more than 101.5)). On an unknown date, the patient experienced PAIN IN EXTREMITY (a little pain in the arm). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK, q4h. On 21-Mar-2021, TREMOR (trembling), CHILLS (chills) and PYREXIA (had fever (that was never more than 101.5)) had resolved. At the time of the report, MALAISE (malaise in the body) and PAIN IN EXTREMITY (a little pain in the arm) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101.5 (High) fever. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. Patient stated that it felt like COVID-19 symptoms which occurred previously.

Other Meds:

Current Illness:

ID: 1570509
Sex: F
Age: 24
State: TX

Vax Date: 03/22/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case was reported by a patient and describes the occurrence of EXPOSURE VIA BREAST MILK (breastfeeding) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination. No Medical History information was reported. On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPOSURE VIA BREAST MILK (breastfeeding). At the time of the report, EXPOSURE VIA BREAST MILK (breastfeeding) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were reported. No treatment was provided for the event that was reported. Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: Live follow up received.No new information was updated.

Other Meds:

Current Illness:

ID: 1570510
Sex: F
Age: 56
State: CA

Vax Date: 03/19/2021
Onset Date: 03/19/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: little bit red at the injection site; like bruises (in the arm of the injection); little spot, like chicken skin; really sick; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (really sick), ADMINISTRATION SITE BRUISE (like bruises (in the arm of the injection)), SKIN TEXTURE ABNORMAL (little spot, like chicken skin) and VACCINATION SITE ERYTHEMA (little bit red at the injection site) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. No Medical History information was reported. On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced ILLNESS (really sick). On 21-Mar-2021, the patient experienced ADMINISTRATION SITE BRUISE (like bruises (in the arm of the injection)) and SKIN TEXTURE ABNORMAL (little spot, like chicken skin). On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (little bit red at the injection site). At the time of the report, ILLNESS (really sick), ADMINISTRATION SITE BRUISE (like bruises (in the arm of the injection)), SKIN TEXTURE ABNORMAL (little spot, like chicken skin) and VACCINATION SITE ERYTHEMA (little bit red at the injection site) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications included blood pressure medication. No treatment medication was reported.

Other Meds:

Current Illness:

ID: 1570511
Sex: M
Age: 66
State: WI

Vax Date: 02/26/2021
Onset Date: 02/27/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: pure liquid diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (pure liquid diarrhea) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. No Medical History information was reported. On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced DIARRHOEA (pure liquid diarrhea). At the time of the report, DIARRHOEA (pure liquid diarrhea) outcome was unknown. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Mar-2021, SARS-CoV-2 antibody test: negative (Negative) negative. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment included fewamount supplements and prescribed medications. No concomitant medication was reported.

Other Meds:

Current Illness:

ID: 1570512
Sex: F
Age: 89
State: MD

Vax Date: 03/11/2021
Onset Date: 03/11/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: initial arm pain; Felt thirsty; felt like she was out of breathe; Slept for three days; Upper back back like she stood to long; Felt sick; Felt nausea; Had Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (initial arm pain), THIRST (Felt thirsty), DYSPNOEA (felt like she was out of breathe), HYPERSOMNIA (Slept for three days) and BACK PAIN (Upper back back like she stood to long) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced PAIN IN EXTREMITY (initial arm pain), THIRST (Felt thirsty), DYSPNOEA (felt like she was out of breathe), HYPERSOMNIA (Slept for three days), BACK PAIN (Upper back back like she stood to long), ILLNESS (Felt sick), NAUSEA (Felt nausea) and HEADACHE (Had Headache). At the time of the report, PAIN IN EXTREMITY (initial arm pain), THIRST (Felt thirsty), DYSPNOEA (felt like she was out of breathe), HYPERSOMNIA (Slept for three days), BACK PAIN (Upper back back like she stood to long), ILLNESS (Felt sick), NAUSEA (Felt nausea) and HEADACHE (Had Headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment drug used was Bayer Aspirin

Other Meds:

Current Illness:

ID: 1570513
Sex: F
Age: 76
State: CA

Vax Date: 03/05/2021
Onset Date: 03/06/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Left arm tingling; Physically "out of it"; Mentally "out of it", felt like it could kill patient; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PARAESTHESIA (Left arm tingling), MALAISE (Physically "out of it") and FEELING ABNORMAL (Mentally "out of it", felt like it could kill patient) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination. Concurrent medical conditions included Thyroid disorder NOS and Blood pressure high. On 05-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, the patient experienced MALAISE (Physically "out of it") and FEELING ABNORMAL (Mentally "out of it", felt like it could kill patient). On 13-Mar-2021, the patient experienced VACCINATION SITE PARAESTHESIA (Left arm tingling). At the time of the report, VACCINATION SITE PARAESTHESIA (Left arm tingling) had not resolved and MALAISE (Physically "out of it") and FEELING ABNORMAL (Mentally "out of it", felt like it could kill patient) was resolving. Not Provided Concomitant medication use included thyroid medication and high blood pressure medication. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not applicable. Reporter did not allow further contact Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: No specific follow-up information recorded.

Other Meds:

Current Illness: Blood pressure high; Thyroid disorder NOS

ID: 1570514
Sex: F
Age: 61
State: TX

Vax Date: 02/26/2021
Onset Date: 03/16/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: contracted COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (contracted COVID-19) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. No Medical History information was reported. On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, the patient experienced COVID-19 (contracted COVID-19). At the time of the report, COVID-19 (contracted COVID-19) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medication was reported. No treatment medication was reported.

Other Meds:

Current Illness:

ID: 1570515
Sex: M
Age: 98
State: ME

Vax Date: 02/10/2021
Onset Date: 03/10/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Weakness; Dizzy; Nausea; Headache; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weakness), DIZZINESS (Dizzy), NAUSEA (Nausea) and HEADACHE (Headache) in a 98-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016M20A and 044A2) for COVID-19 vaccination. No Medical History information was reported. On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced ASTHENIA (Weakness), DIZZINESS (Dizzy), NAUSEA (Nausea) and HEADACHE (Headache). At the time of the report, ASTHENIA (Weakness), DIZZINESS (Dizzy), NAUSEA (Nausea) and HEADACHE (Headache) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter. The patient stated doing very good right now and had no problems. No treatment information was provided. The patient received both scheduled doses of mRNA-1273 prior to the events therefore, action taken with the drug in response to the events was not applicable. This case was linked to MOD-2021-053413 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Follow up received , adverse events outcome and case narrative were updated.

Other Meds:

Current Illness:

ID: 1570516
Sex: M
Age: 75
State: NJ

Vax Date: 01/25/2021
Onset Date: 03/21/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: face got warm; he felt tired; face got a little reddish; This spontaneous case was reported by a patient and describes the occurrence of FEELING HOT (face got warm), ERYTHEMA (face got a little reddish) and FATIGUE (he felt tired) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 006M20A) for COVID-19 vaccination. Concurrent medical conditions included Arthritis and Eye disorder. Concomitant products included PARACETAMOL (TYLENOL) for Arthritis, SELENOMETHIONINE (75 SE), XANTOFYL (LUTEIN-VISION) for Eye disorder. On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Mar-2021, the patient experienced ERYTHEMA (face got a little reddish). On an unknown date, the patient experienced FEELING HOT (face got warm) and FATIGUE (he felt tired). At the time of the report, FEELING HOT (face got warm), ERYTHEMA (face got a little reddish) and FATIGUE (he felt tired) was resolving. On an unspecified date, the patient felt tired and face got warm and after taking paracetamol he felt better. On 21-MAR-2021 night, his face got warm again and l little reddish and after taking paracetamol he felt better. Action taken with mRNA-1273 in response to events was not applicable.

Other Meds: TYLENOL; LUTEIN-VISION

Current Illness: Arthritis; Eye disorder

ID: 1570517
Sex: F
Age: 32
State: UT

Vax Date: 02/06/2021
Onset Date: 03/07/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pregnancy; headache; This spontaneous retrospective pregnancy case was reported by a consumer and describes the occurrence of HEADACHE (headache) and EXPOSURE DURING PREGNANCY (Pregnancy) in a 42-year-old female patient (gravida 1, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A and 007M20A) for COVID-19 vaccination. There was no medical history reported by the reporter. Concurrent medical conditions included Type 1 diabetes mellitus and Hashimoto's disease. Concomitant products included INSULIN ASPART (NOVOLOG) for Diabetes, LEVOTHYROXINE for Hashimoto's disease, MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for Pregnancy. On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 01-Jul-2020 and the estimated date of delivery was 07-Apr-2021. On 07-Mar-2021, the patient experienced HEADACHE (headache). On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (Pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the thirty-fifth week of the pregnancy. The delivery occurred on 15-Mar-2021. The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency. On 11-Mar-2021, HEADACHE (headache) had resolved. At the time of the report, EXPOSURE DURING PREGNANCY (Pregnancy) had resolved. The reporter reported that there had not been any complications or acute illnesses during this pregnancy to date The patient did not had a family history of congenital anomalies/genetic disease. The reporter reported that the patient did not use alcohol, nicotine, marijuana or any other illicit substance in past or present.

Other Meds: NOVOLOG; LEVOTHYROXINE; PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]

Current Illness: Hashimoto's disease; Type 1 diabetes mellitus

ID: 1570518
Sex: F
Age: 53
State: NM

Vax Date: 02/08/2021
Onset Date: 03/09/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Load of panic attacks; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PANIC ATTACK (Load of panic attacks) and PYREXIA (Fever) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 02AL20A and 013L20A) for COVID-19 vaccination. The patient's past medical history included Anxiety. Concomitant products included BUPROPION for COVID-19 vaccination, LORAZEPAM for an unknown indication. On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced PYREXIA (Fever). On 14-Mar-2021, the patient experienced PANIC ATTACK (Load of panic attacks). At the time of the report, PANIC ATTACK (Load of panic attacks) and PYREXIA (Fever) outcome was unknown. Not Provided No treatment medications were reported.

Other Meds: LORAZEPAM; BUPROPION

Current Illness:

ID: 1570519
Sex: F
Age: 58
State: FL

Vax Date: 03/18/2021
Onset Date: 03/21/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: feels so weak; fever; Severe throbbing headache; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (feels so weak), PYREXIA (fever) and HEADACHE (Severe throbbing headache) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. No Medical History information was reported. On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Mar-2021, the patient experienced ASTHENIA (feels so weak), PYREXIA (fever) and HEADACHE (Severe throbbing headache). At the time of the report, ASTHENIA (feels so weak), PYREXIA (fever) and HEADACHE (Severe throbbing headache) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant concomitant medications were reported. Treatment detail included that the patient took Tylenol.

Other Meds:

Current Illness:

ID: 1570520
Sex: F
Age:
State: WA

Vax Date: 03/21/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: pains; She stated that before the had the vaccine she took 1 Advil. Wanted to know if this will affect the antibody development; achy joints; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (pains), DRUG INTERACTION (She stated that before the had the vaccine she took 1 Advil. Wanted to know if this will affect the antibody development) and ARTHRALGIA (achy joints) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (pains), DRUG INTERACTION (She stated that before the had the vaccine she took 1 Advil. Wanted to know if this will affect the antibody development) and ARTHRALGIA (achy joints). At the time of the report, PAIN (pains), DRUG INTERACTION (She stated that before the had the vaccine she took 1 Advil. Wanted to know if this will affect the antibody development) and ARTHRALGIA (achy joints) outcome was unknown. No concomitant medication was not reported. No treatment medication was not reported Action taken with mRNA-1273 in response to the event was not applicable. Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Vaccine Information, second dose added.

Other Meds:

Current Illness:

ID: 1570521
Sex: F
Age: 17
State: WA

Vax Date: 03/19/2021
Onset Date: 03/19/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Moderna vaccine to a 17 year old; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Moderna vaccine to a 17 year old) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038A21A and 045B21A) for COVID-19 vaccination. No Medical History information was reported. On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Moderna vaccine to a 17 year old). On 19-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Moderna vaccine to a 17 year old) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medication was reported No treatment medication was reported Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Follow-up information received on 11-May-2021, Added Patient Demographics, Suspect drug information.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 599,999

Page last modified: 03 October 2021 5:28pm